Melanotan 2 5 mg: Advanced Melanogenesis and Libido Enhancement Research
Dragon Pharma presents Melanotan 2 5 mg, a sophisticated synthetic peptide that has revolutionized research in melanogenesis stimulation and sexual function. This third-party tested compound (verified 5.56 mg actual content) represents a significant advancement in studying skin pigmentation mechanisms and neuroendocrine function. Melanotan 2’s unique ability to activate multiple melanocortin receptors makes it invaluable for researching not only skin tanning but also libido enhancement, appetite suppression, and metabolic effects. For bodybuilders and fitness enthusiasts, Dragon Pharma’s Melanotan 2 offers comprehensive research opportunities in cosmetic enhancement, sexual health, and metabolic regulation through melanocortin system modulation.
DRUG DESCRIPTION
Dragon Pharma’s Melanotan 2 is supplied as a sterile, lyophilized powder in a 5 mg / 2 mL vial, with independent laboratory verification showing 5.56 mg actual content (test date: 2025-04-18). Melanotan 2 is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that has been structurally modified for enhanced stability, prolonged half-life, and increased potency. The peptide functions as a non-selective agonist of melanocortin receptors, primarily targeting MC1R (responsible for melanogenesis and skin pigmentation), MC3R, and MC4R (involved in appetite regulation, sexual function, and energy homeostasis). Unlike natural α-MSH, Melanotan 2 demonstrates significantly greater resistance to enzymatic degradation, allowing for less frequent administration and more sustained receptor activation. Its broad receptor activation profile enables research across multiple physiological systems, making it one of the most versatile melanocortin agonists available for scientific study.
MELANOTAN 2 PROFILE
Drug Class: Synthetic Melanocortin
Main Active Substance: Melanotan II
Concentration: 5 mg/vial
Presentation: 2 mL Vial
Elimination Half-Life: ~2-3 hours
Recommended Dosage: 250-500 mcg daily
Anabolic Ratio: N/A
Androgenic Ratio: N/A
Acne: Possible
Hepatotoxicity: Low
Aromatization: No
Manufacturer: Dragon Pharma
LAB TEST REPORT
Dragon Pharma’s commitment to quality assurance is demonstrated through rigorous third-party testing of all research compounds. Laboratory analysis conducted on April 18, 2025, verified that our Melanotan 2 5 mg vials contain 5.56 mg of active substance, representing a 111.2% potency confirmation that significantly exceeds the labeled amount.
The testing utilized advanced high-performance liquid chromatography (HPLC) with UV detection to ensure accurate quantification and purity verification. This independent validation is particularly important for Melanotan 2 research, as inconsistent dosing could lead to variable pigmentation results or unpredictable side effect profiles. The substantial overfill provides researchers with additional assurance of receiving the full intended dose while accounting for any minor losses during reconstitution and administration.
HOW TO USE MELANOTAN 2
For research purposes, Melanotan 2 5 mg is reconstituted with bacteriostatic water. Research protocols typically involve subcutaneous administration, with dosing strategies varying based on research objectives. For melanogenesis studies, common protocols involve daily administration of 250-500 mcg, often beginning with a “loading phase” of 5-10 days followed by maintenance dosing 2-3 times weekly. The peptide is frequently administered 30-60 minutes before UV exposure in tanning research. Melanotan 2 is often researched in combination with other compounds for enhanced effects. It can be combined with PT-141 for comprehensive sexual function research through complementary melanocortin receptor activation. For body recomposition studies, it pairs effectively with Clenbuterol for appetite suppression and metabolic enhancement. During cutting phases with compounds like T3 (Cytomel), Melanotan 2 provides additional metabolic support through MC4R activation. For overall wellness during intense training, it can be stacked with BPC-157 for comprehensive recovery support. For researchers using compounds that may suppress libido like Superdrol 10, Melanotan 2 offers potential mitigation through its pro-sexual effects.
POSSIBLE SIDE EFFECTS
Melanotan 2 is generally well-tolerated in research settings, though its broad receptor activation profile can produce various transient effects. The most common side effects include facial flushing, nausea, and appetite suppression shortly after administration, which typically diminish with continued use. Many research subjects report spontaneous erections in males and increased libido in both sexes due to MC3R and MC4R activation. Some subjects experience mild fatigue or yawning episodes after injection. The melanogenesis effects can cause freckles and moles to darken temporarily, and excessive dosing may lead to hyperpigmentation in unintended areas. Unlike many research compounds, Melanotan 2 does not cause organ toxicity, hormonal suppression, or significant long-term health concerns when used at appropriate research doses. The verified purity of Dragon Pharma’s formulation ensures researchers avoid contaminants that could cause allergic reactions or inconsistent results.
CONCLUSION
Dragon Pharma’s Melanotan 2 5 mg represents a versatile and powerful tool for melanocortin system research, offering verified purity and substantial overfill for reliable dosing. Its unique ability to simultaneously influence skin pigmentation, sexual function, appetite regulation, and energy homeostasis through multiple melanocortin receptors makes it invaluable for comprehensive physiological studies. The third-party verified potency ensures researchers can achieve consistent, reproducible results across various research applications. When implemented within structured research protocols that account for its dose-dependent effects and include proper UV exposure management in tanning studies, Melanotan 2 can yield significant insights into melanogenesis mechanisms, sexual health optimization, and metabolic regulation. For researchers exploring the multifaceted roles of the melanocortin system in human physiology, Dragon Pharma’s tested Melanotan 2 provides a reliable, effective foundation for groundbreaking studies.
MELANOTAN 2 FAQ
Initial skin darkening can typically be observed within 3-5 days of daily administration, with significant tanning effects becoming apparent after 1-2 weeks of consistent dosing combined with moderate UV exposure. The peptide stimulates melanin production rather than causing immediate pigment changes.
The tanning effects are not permanent but can be long-lasting. Without maintenance dosing, the enhanced pigmentation typically fades over 4-8 weeks as naturally pigmented skin cells are shed and replaced. However, existing moles and freckles may maintain some darkening between cycles.
Melanotan 2 has broader melanocortin receptor activity (affecting MC1R, MC3R, and MC4R) compared to Melanotan 1’s more selective MC1R targeting. This gives Melanotan 2 additional effects on libido and appetite but may also cause more side effects. Melanotan 2 also has a longer half-life and greater potency.
While Melanotan 2 will stimulate melanin production without UV exposure, the tanning effect is significantly enhanced and more evenly distributed with moderate UV exposure. However, researchers should emphasize that excessive UV exposure carries independent health risks regardless of peptide use.
Yes, many researchers focus specifically on Melanotan 2’s sexual function applications. The pro-sexual effects occur independently of tanning and can be studied through appropriate dosing protocols and outcome measures. For scientific context, see: National Library of Medicine – Melanocortin System.